Article-by-article contents · Page 2 / 2

Medical Products, Pharmacy Profession and Pharmaceutical Establishments Lawarticles 101–183

  1. Article 101 — Article (101) Prohibitions

    The Medical Warehouse or Medical Store may not: 1. Practicing any activity not licensed. 2. Delivering or selling Medical Products or raw materials to parties other than those licensed to trade in these products. 3. Impo

  2. Article 102 — Article (102) License Suspension and Precautionary Closure

    1. The EDE shall issue a decision to temporarily suspend the License of the Medical Warehouse or Medical Store, in any of the following cases: a. Withdraw, cancel or non-renew Certificate of Good Practice for Warehousing

  3. Article 103 — Article (103) License Cancellation

    The EDE shall issue a decision to cancel the License of the Medical Warehouse or Medical Store, in any of the following cases: 1. The Medical Warehouse or Medical Store is practicing an activity for which it is not licen

  4. Article 104 — Article (104) Maintain a Public Record or Information System

    1. The Pharmacist in charge or the person in charge of the Medical Warehouse or Medical Store shall maintain a general record or information system, in which the type and quantity of Medical Products received by the ware

  5. Article 105 — Article (105) Setting the Price of the Medical Product

    1. The Medical Warehouse shall place the selling price to the public on the outer packaging of the Medical Product subject to pricing and approved by the EDE in a clear and easy-to-read manner before selling and deliveri

  6. Article 106 — Article (106) License Conditions

    1. No person may open a Marketing Office unless he has obtained a license from the EDE. 2. The following conditions shall be met to obtain a license to open a Marketing Office: a. Providing evidence that the Applicant fo

  7. Article 107 — Article (107) License Term and Renewal

    1. The License to open a Marketing Offices shall be valid for a period of not less than one year, renewable. The License holder shall comply with practicing the licensed activity during the specified period of validity o

  8. Article 108 — Article (108) Transfer or Assignment of Marketing Office

    1. Subject to the legislation in force in the State, the Marketing Office may not be moved from one place to another without the approval of the EDE. 2. Without prejudice to the legislation in force in the State, the Own

  9. Article 109 — Article (109) Prohibitions

    The Marketing Office may not: 1. Practice any activity not licensed. 2. Importing or storing Medical Products for sale or distribution. 3. Dealing with other unlicensed Pharmaceutical Establishments. 4. Any other prohibi

  10. Article 110 — Article (110) Introductory Materials, Products and Free Samples

    1. The Marketing Office may, through the licensed Medical Warehouse appointed by it, import the Medical Products necessary for it to perform its activity after obtaining approval from the EDE in accordance with the provi

  11. Article 111 — Article (111) License Suspension and Precautionary Closure

    1. The EDE shall issue a decision to temporarily suspend the License of the Marketing Office, in any of the following cases: a. Transfer of Ownership of the Marketing Office to another person without the approval of the

  12. Article 112 — Article (112) License Cancellation

    The EDE shall issue a decision to cancel the License of the Marketing Office, in any of the following cases: 1. The Marketing Office is carrying out an unlicensed activity. 2. If it is proven that obtaining the license t

  13. Article 113 — Article (113) License Conditions

    1. No person may open a Pharmaceutical Consulting Office unless he has obtained a license from the EDE. 2. The following conditions shall be met to obtain a license to open a Pharmaceutical Consulting Office: a. To entru

  14. Article 114 — Article (114) License Term and Renewal

    1. The License to open a Pharmaceutical Consulting Office shall be valid for a period of not less than one year, renewable. The License holder shall comply with practicing the licensed activity during the specified perio

  15. Article 115 — Article (115) Transfer or Assignment of Ownership of the Pharmaceutical Consulting Office

    1. Subject to the legislation in force in the State, the Pharmaceutical Consulting Office may not be moved from one place to another without the approval of the EDE. 2. Without prejudice to the legislation in force in th

  16. Article 116 — Article (116) Prohibitions

    Pharmaceutical Consulting Office may not: 1. Practicing any activity not licensed. 2. Import, export, store, distribute or sell any Medical Products. 3. Providing advice or consultations to areas and establishments outsi

  17. Article 117 — Article (117) License Suspension and Precautionary Closure

    1. The EDE shall issue a decision to temporarily suspend the License of the or Pharmaceutical Consulting Office, in any of the following cases: a. Transfer of Ownership of the Pharmaceutical Consulting Office to another

  18. Article 118 — Article (118) License Cancellation

    The EDE may issue a decision to cancel the license of the Pharmaceutical Consulting Office, in any of the following cases: 1. The Pharmaceutical Consulting Office is practicing an unlicensed activity. 2. If it is proven

  19. Article 119 — Article (119) License Conditions

    1. No person may open a Pharmaceutical Laboratory unless he has obtained a license from the EDE. 2. The following conditions shall be met to obtain a license to open a Pharmaceutical Laboratory: a. Obtain a valid Good La

  20. Article 120 — Article (120) License Term and Renewal

    1. The License to open a Pharmaceutical Laboratory shall be valid for a period of not less than one year, renewable. The License holder shall comply with practicing the licensed activity during the specified period of va

  21. Article 121 — Article (121) Pharmaceutical Laboratory Obligations

    1. The licensed Pharmaceutical Laboratory shall comply with the standards of good laboratory practice approved by the EDE. 2. The person responsible for the Pharmaceutical Laboratory shall approve the certificates of the

  22. Article 122 — Article (122) Transfer or Assignment of Ownership of the Pharmaceutical Laboratory

    1. Subject to the legislation in force in the State, it is not permitted to move the Pharmaceutical Laboratory from one place to another, or make any change in its plan in accordance with which its license was issued, wi

  23. Article 123 — Article (123) Prohibitions

    The Pharmaceutical Laboratory may not: 1. Practicing any activity not licensed. 2. Importing or storing Medical Products for sale or advertisement or presenting 3. Conducting any research or testing on humans for any rea

  24. Article 124 — Article (124) License Suspension and Precautionary Closure

    1. The EDE shall issue a decision to temporarily suspend the License of the Pharmaceutical Laboratory, in any of the following cases: a. Transfer of Ownership of the Pharmaceutical Laboratory to another person without th

  25. Article 125 — Article (125) License Cancellation

    The EDE may issue a decision to cancel the License of the Pharmaceutical Laboratory, in any of the following cases: 1. The Pharmaceutical Laboratory is practicing an activity for which it is not licensed. 2. If it is pro

  26. Article 126 — Article (126) License Conditions

    1. No person may open a Medical Product Factories and Contracting Companies Manufacture Medical Products unless he has obtained a license from the EDE. 2. The following conditions shall be met to obtain a license to open

  27. Article 127 — Article (127) Quality Management Standards and Good Manufacturing Practices

    The Medical Products Manufacturer and the contracted Medical Products manufacturing company shall comply with the quality management standards and good manufacturing practices controls issued and approved by the EDE.

  28. Article 128 — Article (128) License Term and Renewal

    1. The License to open a Medical Product Factories and Contracting Companies Manufacture Medical Products shall be valid for a period of not less than one year, renewable. The License holder shall comply with practicing

  29. Article 129 — Article (129) Transfer of the Medical Product Factories and Contracting Companies Manufacture Medical Products or Waiving their Ownership, Taking into Account

    1. Subject to the legislation in force in the State, no Medical Product Factories and Contracting Companies Manufacture Medical Products may be transferred from one place to another, or any change made to its plan under

  30. Article 130 — Article (130) Prohibitions

    Medical Product Factories and Contracting Companies Manufacture Medical Products may not: 1. Practicing any activity not licensed. 2. Remanufacturing a Medical Product that has a valid Marketing Approval with new technic

  31. Article 131 — Article (131) License Suspension and Precautionary Closure

    1. The EDE shall issue a decision to temporarily suspend the License of Medical Product Factories and Contracting Companies Manufacture Medical Products, in any of the following cases: a. Transfer of Ownership of the Fac

  32. Article 132 — Article (132) License Cancellation

    The EDE shall issue a decision to temporarily cancel the License of Medical Product Factories and Contracting Companies Manufacture Medical Products, in any of the following cases: 1. The factory or contracting company i

  33. Article 133 — Article (133) Setting the Price of the Medical Product

    1. The Medical Product Factories and Contracting Companies Manufacture Medical Products shall place the selling price to the public on the outer packaging of the Medical Product subject to pricing and approved by the EDE

  34. Article 134 — Article (134) License Conditions

    1. No person may open a Licensing Contractual Company for Research and Development unless he has obtained a license from the Ministry or the Competent Health Authority, each within the limits of their jurisdiction. 2. Th

  35. Article 135 — Article (135) License Term and Renewal

    1. The License to open Contractual Company for Research and Development shall be valid for a period of not less than one year, renewable. The License holder shall comply with practicing the licensed activity during the s

  36. Article 136 — Article (136) Transfer or Assignment of Ownership of the Contractual Company for Research and Development

    1. Subject to the legislation in force in the State, no Contractual Company for Research and Development may be transferred from one place to another, or any change made to its plan under which it was licensed, without t

  37. Article 137 — Article (137) Prohibitions

    The Contractual Company for Research and Development may not: 1. Practicing any activity not licensed. 2. Circulation in counterfeit or unusable products. 3. Manufacture of products for non-Research and Development purpo

  38. Article 138 — Article (138) License Suspension and Precautionary Closure

    1. The Ministry or the Competent Health Authority, each within their jurisdiction, shall issue a decision to temporarily suspend the License of Contractual Company for Research and Development for a period not exceeding

  39. Article 139 — Article (139) License Cancellation

    The EDE or the Competent Health Authority, each within their jurisdiction, shall issue a decision to cancel the License of the Contractual Company for Research and Development, in any of the following cases: 1. The Contr

  40. Article 140 — Article (140) License Conditions

    1. No person may open a Biobank unless he has obtained a license from the Ministry or the Competent Health Authority, each within the limits of their jurisdiction. 2. The following conditions shall be met to obtain a lic

  41. Article 141 — Article (141) Licensing of Blood Storage Units in Government and Private Health Establishments

    1. Blood storage units may not be established in government or private Health Establishments without obtaining a license from the Ministry or the Competent Health Authority, each within the limits of their jurisdiction.

  42. Article 142 — Article (142) License Term and Renewal

    1. The License to open a Biobank shall be valid for a period of not less than one year, renewable. The License holder shall comply with practicing the licensed activity during the specified period of validity of the Lice

  43. Article 143 — Article (143) Transfer or Assignment of Biobank

    1. Subject to the legislation in force in the State, no Biobank may be transferred from one place to another, or any change made to its plan under which it was licensed, without the approval of the Ministry or the Compet

  44. Article 144 — Article (144) Prohibitions

    Biobank may not: 1. Practicing any activity not licensed. 2. Importing or exporting biological samples without obtaining the approval of the Competent Health Establishment or Authority, each within the limits of their ju

  45. Article 145 — Article (145) License Suspension and Precautionary Closure

    1. The EDE or the Competent Health Authority, each within their jurisdiction, shall issue a decision to temporarily suspend the License of the Biobank, in any of the following cases: a. Transferring Ownership of a Bioban

  46. Article 146 — Article (146) License Cancellation

    1. The Competent Health Establishment or Authority, each within the limits of their jurisdiction, may issue a decision to cancel the Biobank license, in any of the following cases: a. The Biobank is carrying out an unlic

  47. Article 147 — Article (147) License Conditions

    1. No person may open Non-Clinical and Clinical Research Entity unless he has obtained a license from the EDE or the Competent Health Authority, each within the limits of their jurisdiction. 2. The following conditions s

  48. Article 148 — Article (148) License Term and Renewal

    1. The License to open Clinical and Non-Clinical Research Entity shall be valid for a period of not less than one year, renewable. The License holder shall comply with practicing the licensed activity during the specifie

  49. Article 149 — Article (149) Transfer or Assignment of Ownership of Non-Clinical and Clinical Research

    1. Subject to the legislation in force in the State, Clinical and Non-Clinical Research Entity may be transferred from one place to another, or any change made to its plan under which it was licensed, without the approva

  50. Article 150 — Article (150) Prohibitions

    Non-Clinical and Clinical Research Entities may not: 1. Practicing any activity not licensed. 2. Conducting any clinical or non-Clinical Research without obtaining the necessary approvals in accordance with the relevant

  51. Article 151 — Article (151) License Suspension and Precautionary Closure

    1. The Ministry or the Competent Health Authority, each within their jurisdiction, shall issue a decision to temporarily suspend the License of the Non-Clinical and Clinical Research Entity for a period not exceeding one

  52. Article 152 — Article (152) License Cancellation

    The EDE or the Competent Health Authority, each within their jurisdiction, shall issue a decision to cancel the License of the Non-Clinical and Clinical Research Entity, in any of the following cases: 1. The Non-Clinical

  53. Article 153 — Article (153) License Conditions

    1. No person may open Bioequivalence Centre unless he has obtained a license from the EDE or the Competent Health Authority, each within the limits of their jurisdiction. 2. The following conditions shall be met to obtai

  54. Article 154 — Article (154) License Term and Renewal

    1. The License to open Bioequivalence Centre shall be valid for a period of not less than one year, renewable. The License holder shall comply with practicing the licensed activity during the specified period of validity

  55. Article 155 — Article (155) Transfer or Transfer of Bioequivalence Centre

    1. Subject to the legislation in force in the State, no Bioequivalence Centre may be transferred from one place to another, or any change made to its plan under which it was licensed, without the approval of the Ministry

  56. Article 156 — Article (156) Prohibitions

    Bioequivalence Centre may not: 1. Practicing any activity not licensed. 2. Conducting any clinical or non-Clinical Research without obtaining the necessary approvals in accordance with the relevant legislation. 3. Import

  57. Article 157 — Article (157) License Suspension and Precautionary Closure

    1. The EDE or the Competent Health Authority, each within their jurisdiction, shall issue a decision to temporarily suspend the License of the Bioequivalence Centre, in any of the following cases: a. Withdraw or cancel o

  58. Article 158 — Article (158) License Cancellation

    The EDE or the Competent Health Authority, each within their jurisdiction, shall issue a decision to cancel the license of the Bioequivalence Centre, in any of the following cases: 1. The Bioequivalence Centre is carryin

  59. Article 159 — Article (159) Control and Inspection

    1. The EDE, Ministry or Competent Health Authority, each within the limits of their jurisdiction, shall supervise the compliance of Pharmaceutical Establishments and Biobanks with the provisions of this Decree-Law, its E

  60. Article 160 — Article (160) Disciplinary Sanctions

    1. Without prejudice to the criminal penalties stipulated in this Decree-Law or any other laws, the EDE, Ministry or Competent Health Authority, each within the limits of their jurisdiction, may impose any of the followi

  61. Article 161 — Article (161) Penalty Record

    A record shall be established in each of the EDE, the Ministry and the Competent Health Authority, in which the penalties imposed on License Holders shall be recorded. These authorities shall exchange data on violations

  62. Article 162 — Article (162) Appeal Against Disciplinary Penalty

    1. Anyone against whom a disciplinary penalty decision has been issued in accordance with Article (160) of this Decree-Law may appeal the decision before the Appeals Committee referred to in Article (170) of this Decree-

  63. Article 163 — Article (163) Non-Prejudice to Criminal and Civil Liability

    Disciplinary accountability in accordance with the provisions of this Decree-Law shall not prejudice criminal or civil liability, where applicable.

  64. Article 164 — Article (164)

    1. Any one who shall be punished by imprisonment for a period of not less than (6) six months and not exceeding (2) two years and a fine of not less than (50,000) fifty thousand AED and not more than (200,000) two hundre

  65. Article 165 — Article (165)

    1. Any one who shall be punished by imprisonment for a period of not less than (6) six months and not exceeding one year and a fine of not less than (50,000) fifty thousand AED and not more than (200,000) two hundred tho

  66. Article 166 — Article (166)

    A fine not exceeding two one hundred thousand AED (100,000) shall be imposed on any person who: 1. Violation of the approved pricing of Medical Products by the EDE, and the penalty will be doubled in the event of recurre

  67. Article 167 — Article (167)

    Imprisonment and a fine not less than on two hundred thousand AED (200,000) and not exceeding two million AED (1,000,000) shall be imposed on any person who: 1. Fraud or counterfeiting a Medical Product, raw materials or

  68. Article 168 — Article (168) Additional Penalties

    1. In all cases, the court may, in addition to the prescribed penalties, rule to close the Pharmaceutical Establishment or Biobank for a period not exceeding (3) three months or to close it permanently with the withdrawa

  69. Article 169 — Article (169) Non-Prejudice to a More Severe Penalty

    The Application of the penalties stated in this Decree shall not prejudice any more severe penalty provided by any other law.

  70. Article 170 — Article (170) Appeal Against Decisions Issued in Implementation of the Provisions of this Decree-Law

    Subject to Article (162) of this Decree-Law, anyone against whom a decision has been issued in implementation of the provisions of this Decree-Law may file a grievance before the Grievance Committee formed for this purpo

  71. Article 171 — Article (171) Practising the Profession of Pharmacy in Government Agencies

    The Ministry, the Competent Health Authority, the federal Health Authority, and the federal and local non-health government authority may appoint Pharmacists to practice the profession, provided that they obtain a licens

  72. Article 172 — Article (172) Judicial Police Officers

    By a decision of the Minister of Justice in agreement with the Chairman or the Minister, or by a decision of the head of the competent local judicial authority in agreement with the head of the competent health authority

  73. Article 173 — Article (173) Obtaining the Required Licenses

    Obtaining the Licenses stipulated in this Decree-Law does not exempt from obtaining other licenses required by the laws, regulations or systems in force in the State.

  74. Article 174 — Article (174) Mutual Notice

    The EDE, the Ministry and the Competent Health Authority shall establish a mechanism for mutual notification of licenses issued by them to Pharmaceutical Establishments and Biobanks and any information related thereto.

  75. Article 175 — Article (175) Regularization

    Those who are under the provisions of this Law at the time of its issuance shall regularize their status in accordance with its provisions within a period not exceeding one year from the date of enforcement. This period

  76. Article 176 — Article (176) Executive Resolutions

    1. The Executive Regulations of this Decree-Law shall specify, in particular, the terms and conditions of the following: a. Providing the necessary Pharmaceutical Products and medical supplies to meet the community needs

  77. Article 177 — Article (177) Fees and Fines

    The Cabinet shall issue, based on the proposal of the Minister of Finance, the necessary decisions to determine the fees for services provided by the EDE, the Ministry, and the Ministry of Interior, in implementation of

  78. Article 178 — Article (178) Authorization

    The Cabinet may issue a decision to delegate some of the powers of the Ministry or institution stipulated in this Decree-Law to any federal or local government EDE, based on the proposal of the minister or the president,

  79. Article 179 — Article (179) Committees

    The Cabinet may establish one or more committees based on the President proposal to enable the EDE to exercise its powers stipulated in this Decree-Law.

  80. Article 180 — Article (180) Repeals

    1. The aforementioned Federal Law No. (8) of 2019 is hereby repealed, as well as any provision that violates or contradicts the provisions of this Decree-Law. 2. The regulations and resolutions applying the aforementione

  81. Article 181 — Article (181) Publication and Entry into Force of Decree-Law

    This Decree-Law shall be published in the Official Gazette and shall enter into force as of January 02, 2025.

  82. Article Schedule 1 — List No. (1) - Chemical Precursors

    List No. (1) - Chemical name in English; chemical name in Arabic; IUPAC synonym; CAS number: 1. N-Phenethyl-4-piperidone (NPP); N-فينيتيل-4-بيبيريدون; 1-(2-phenylethyl)-piperidin-4-one; 39742-60-4. 2. 1-Phenyl-2-propanon

  83. Article Schedule 2 — List No. (2) - Chemical Precursors

    List No. (2) - Chemical name in English; chemical name in Arabic; IUPAC synonym; CAS number: 1. Acetone; الأسيتون; 2-propanone; 67-64-1. 2. Anthranilic acid; حمض الأنترانيل; 2-aminobenzoic acid; 118-92-3. 3. Ethyl ether;

WAWhatsAppTGTelegram